Discussion on Health Program Launch and Implementation Strategies

Today, Paul and Mike unpack their opinions about lipids. They talk about true risk for cardiovascular disease, primary versus secondary prevention, lipid lowering drugs, and share their thoughts on a recent podcast episode with Peter Attia.

*Produced by Mountain Valley Media

00:06:08 Blood markers & imaging techniques of metabolic function 

00:14:38 Gene mutations

00:20:28 LDL & Plaque burden

00:27:23 Money in statins

00:31:38 Downsides of lowering LDL

01:21:23 The downsides of popular cholesterol lowering drugs

01:41:07 Should we fear heart attacks?

01:45:23 PCSK9 Inhibitors

01:52:43 Risk profile of Statins 

01:53:02 Risk vs. reward of Ezetimibe

02:04:02 Primary vs. secondary prevention

Resources:

Debunking Sugar Claims: What Dr. Lustig Got Wrong On The Huberman Podcast:

https://www.youtube.com/watch?v=JcEmSgbMfco&t=2933s

Work With Mike: https://mikefave.com/